3rd edition of Informa Markets in India’s flagship healthcare expo to be held August 21–23, 2026, at Bharat Mandapam, New Delhi. Expanded focus on medical manufacturing, digital health, and global partnerships New Delhi, June 12, 2026: Informa Markets in India has announced the third edition of
India, 19 June 2026: BPL Medical Technologies, India's leading medical equipment brand with a rich 50-year legacy under the BPL Group, hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, established in 2024, bringing together key strategic partners and suppliers. The annual platform was
India, 3 June 2026: BPL Medical Technologies, India’s leading medical equipment brand with a 50-year legacy under the BPL Group, has announced the launch of the BPL Vent 300, a new ICU ventilator developed to support critical care teams with advanced respiratory management across adult,
Mumbai, 15th May 2026: India’s medical technology sector is entering a more strategic phase, moving beyond a market-size narrative toward a competitiveness narrative built on capability, quality, and global readiness. This is the key headline from Poised for Takeoff: MedTech in India, a joint report
New Delhi | April 22, 2026 The pricing architecture of India’s medical devices sector has come under renewed scrutiny, with the Association of Indian Medical Devices Industry (AiMeD) welcoming the government’s move to review existing price regulations while urging a comprehensive, evidence-based reform of the current
New Delhi, : India’s healthcare sector is poised for significant expansion, with the market projected to reach ₹12 trillion by FY30, according to recent industry reports. The growth is being driven by increasing healthcare demand, rising incomes, expanding insurance coverage, and rapid adoption of digital
New Delhi, : In a significant step towards improving the regulatory environment for India’s medical devices sector, NITI Aayog and the Department for Promotion of Industry and Internal Trade (DPIIT) have initiated measures to decriminalise minor offences and rationalise penalties under existing regulatory frameworks. The
New Delhi, : In a timely intervention to ease pressure on critical healthcare supply chains, the Government of India has announced customs duty relief measures for the pharmaceutical and medical technology (MedTech) sectors, aiming to address ongoing supply constraints and rising input costs. The move is
New Delhi, [Insert Date]: Emphasizing the need to strengthen India’s healthcare manufacturing ecosystem, Union Minister of State for Health and Family Welfare and Chemicals & Fertilisers Anupriya Patel stated that India is actively working towards achieving self-reliance in the medical devices sector, with a strong
New Delhi | March 2026 India’s medical device industry has urged the government to provide urgent financial relief measures, including temporary duty rebates and faster tax refunds, as escalating geopolitical tensions in West Asia continue to drive up input costs and disrupt supply chains. Industry body
